Cargando…
An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model
An antagonist of human monocyte chemoattractant protein (MCP)-1, which consists of MCP-1(9-76), had previously been characterized and shown to inhibit MCP-1 activity in vitro. To test the hypothesis that, by inhibiting endogenous MCP-1, the antagonist has antiinflammatory activity in vivo, we examin...
Autores principales: | Gong, Jiang-Hong, Ratkay, Leslie G., Waterfield, J. Douglas, Clark-Lewis, Ian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198969/ https://www.ncbi.nlm.nih.gov/pubmed/9207007 |
Ejemplares similares
-
Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions.
por: Ratkay, L G, et al.
Publicado: (1994) -
Monocyte Chemoattractant Protein 1–Dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in Mrl-Fas(lpr) Mice
por: Tesch, Gregory H., et al.
Publicado: (1999) -
Self-Reactivity and the Expression of Memory Markers
Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr
Mice
por: Smyth, Lesley, et al.
Publicado: (1992) -
Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
por: Weinberg, J B
Publicado: (1998) -
Immunomodulatory effects of atorvastatin on MRL/lpr mice
por: Sun, Jing, et al.
Publicado: (2022)